Lexaria Bioscience Corp (LEXX)

Stock price, financials, and technical signals for Lexaria Bioscience Corp (LEXX).

$1.53

-0.14

(-8.38%)

As of 04/03/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

LEXX Performance Snapshot


1-Week Chg

-12.57%

1-Month Chg

19.53%

3-Month Chg

-33.19%

6-Month Chg

-53.78%

1-Year Chg

-55.13%

Year-To-Date Chg

-33.48%

Beta 1-Year

0.90

Beta 5-Year

0.98

Volatility (10-Day)

4.73%

LEXX Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-04-03

$1.53

-$0.14 (-8.38%)

$1.62

$1.64

$1.50

$1.55

127.71K ($195.40K)

2025-04-02

$1.67

$0.03 (1.83%)

$1.68

$1.70

$1.59

$1.65

34.17K ($57.06K)

2025-04-01

$1.64

-$0.07 (-4.09%)

$1.68

$1.68

$1.53

$1.62

79.19K ($129.87K)

2025-03-31

$1.71

-$0.01 (-0.58%)

$1.72

$1.75

$1.67

$1.71

70.93K ($121.29K)

2025-03-28

$1.72

-$0.03 (-1.71%)

$1.72

$1.75

$1.65

$1.71

57.00K ($98.04K)

2025-03-27

$1.75

-$0.05 (-2.62%)

$1.85

$1.85

$1.74

$1.78

19.96K ($34.93K)

2025-03-26

$1.80

-$0.02 (-1.26%)

$1.82

$1.87

$1.75

$1.81

12.69K ($22.80K)

2025-03-25

$1.82

$0.06 (3.41%)

$1.77

$1.85

$1.71

$1.79

78.44K ($142.76K)

2025-03-24

$1.76

-$0.01 (-0.56%)

$1.83

$1.90

$1.75

$1.80

75.01K ($132.01K)

2025-03-21

$1.77

$0.19 (12.03%)

$1.60

$1.79

$1.60

$1.72

188.98K ($334.49K)

LEXX Financials


Balance Sheet

(USD)

2024 Q4

Y/Y CHANGE


  • Cash and equivalents

    $8.08M

    313.39%

  • Total assets

    $9.79M

    170.04%

  • Total liabilities

    $399.72K

    57.34%

  • Total investments

    $39.88K

    -44.94%

  • Shareholders' equity

    $9.77M

    161.17%

  • Book value per share

    $0.59

    41.89%


Income Statement

(USD)

2024 Q4

Y/Y CHANGE


  • Revenue

    $183.92K

    21.58%

  • Net income

    -$2.70M

    -128.15%

  • Operating expense

    $2.87M

    123.39%

  • Gross profit

    $181.20K

    23.73%

  • EBITDA

    -$2.66M

    -132.36%

  • Earnings per share

    -$0.16

    -23.08%


Cash Flow

(USD)

2024 Q4

Y/Y CHANGE


  • Net change in cash

    $1.58M

    162.16%

  • Cash from operations

    -$2.73M

    -130.70%

  • Cash from investing

    -$37.80K

    5.55%

  • Cash from financing

    $4.35M

    138.84%

  • Free cash flow

    -$2.75M

    -132.78%

  • Free cash flow per share

    -$0.17

    -25.95%


Metrics

(USD)

2024 Q4

Y/Y CHANGE


  • Market capitalization

    $36.30M

    135.49%

  • Enterprise value

    $29.94M

    110.44%

  • Shares outstanding

    17.45M

    69.83%

  • Profit margin

    -1470.00%

    -87.64%

  • Gross margin

    98.50%

    1.76%

  • EBITDA margin

    -1446.90%

    -91.11%


Dividends

(USD)

2024 Q4

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    29.64

    37.01%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.